Thrive Capital Management (Pennsylvania)’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-956
| Closed | -$214K | – | 190 |
|
|
2025
Q1 | $214K | Buy |
+956
| New | +$214K | 0.13% | 110 |
|
|
2024
Q4 | – | Sell |
-965
| Closed | -$290K | – | 178 |
|
|
2024
Q3 | $290K | Hold |
965
| – | – | 0.14% | 155 |
|
|
2024
Q2 | $318K | Hold |
965
| – | – | 0.15% | 154 |
|
|
2024
Q1 | $382K | Hold |
965
| – | – | 0.2% | 66 |
|
|
2023
Q4 | $340K | Sell |
965
-6
| -0.6% | -$2.11K | 0.18% | 89 |
|
|
2023
Q3 | $364K | Hold |
971
| – | – | 0.2% | 81 |
|
|
2023
Q2 | $371K | Buy |
971
+9
| +0.9% | +$3.44K | 0.21% | 82 |
|
|
2023
Q1 | $328K | Hold |
962
| – | – | 0.21% | 82 |
|
|
2022
Q4 | $226K | Hold |
962
| – | – | 0.15% | 105 |
|
|
2022
Q3 | $237K | Hold |
962
| – | – | 0.16% | 98 |
|
|
2022
Q2 | $291K | Sell |
962
-10
| -1% | -$3.03K | 0.2% | 80 |
|
|
2022
Q1 | $399K | Buy |
972
+10
| +1% | +$4.11K | 0.24% | 60 |
|
|
2021
Q4 | $451K | Buy |
+962
| New | +$451K | 0.29% | 69 |
|
|
2021
Q3 | – | Sell |
-962
| Closed | -$345K | – | 110 |
|
|
2021
Q2 | $345K | Hold |
962
| – | – | 0.27% | 89 |
|
|
2021
Q1 | $271K | Hold |
962
| – | – | 0.25% | 99 |
|
|
2020
Q4 | $273K | Buy |
+962
| New | +$273K | 0.29% | 69 |
|